Symbol |
Name |
1060P11.3
|
killer cell immunoglobulin-like receptor, three domains, pseudogene
|
A2M
|
alpha-2-macroglobulin
|
ADD3
|
adducin 3 (gamma)
|
ADI1
|
acireductone dioxygenase 1
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1
|
ASPN
|
asporin
|
ATP6V0E2
|
ATPase, H+ transporting V0 subunit e2
|
BMP2
|
bone morphogenetic protein 2
|
BSG
|
basigin (Ok blood group)
|
CALD1
|
caldesmon 1
|
CCL20
|
chemokine (C-C motif) ligand 20
|
CCL5
|
chemokine (C-C motif) ligand 5
|
CD46
|
CD46 molecule, complement regulatory protein
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
CD9
|
CD9 molecule
|
COL1A2
|
collagen, type I, alpha 2
|
COL3A1
|
collagen, type III, alpha 1
|
CSRP2
|
cysteine and glycine-rich protein 2
|
CTGF
|
connective tissue growth factor
|
CTSZ
|
cathepsin Z
|
CXADR
|
coxsackie virus and adenovirus receptor
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
DHRS3
|
dehydrogenase/reductase (SDR family) member 3
|
DUSP1
|
dual specificity phosphatase 1
|
ECM1
|
extracellular matrix protein 1
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
EPAS1
|
endothelial PAS domain protein 1
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
FHL1
|
four and a half LIM domains 1
|
FLT1
|
fms-related tyrosine kinase 1
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
GAA
|
glucosidase, alpha; acid
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
GPX1
|
glutathione peroxidase 1
|
GSN
|
gelsolin
|
GUK1
|
guanylate kinase 1
|
GUSBP3
|
glucuronidase, beta pseudogene 3
|
H2AFV
|
H2A histone family, member V
|
HDAC9
|
histone deacetylase 9
|
HIST1H1C
|
histone cluster 1, H1c
|
HLA-B
|
major histocompatibility complex, class I, B
|
HLA-C
|
major histocompatibility complex, class I, C
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
HLA-F
|
major histocompatibility complex, class I, F
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
IER3
|
immediate early response 3
|
IFI6
|
interferon, alpha-inducible protein 6
|
IFITM1
|
interferon induced transmembrane protein 1
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
IL1RN
|
interleukin 1 receptor antagonist
|
IL7R
|
interleukin 7 receptor
|
JAG1
|
jagged 1
|
KRT5
|
keratin 5, type II
|
LAMP3
|
lysosomal-associated membrane protein 3
|
LDHB
|
lactate dehydrogenase B
|
LEF1
|
lymphoid enhancer-binding factor 1
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
MAOA
|
monoamine oxidase A
|
MMP12
|
matrix metallopeptidase 12
|
MMP9
|
matrix metallopeptidase 9
|
MOXD1
|
monooxygenase, DBH-like 1
|
MSN
|
moesin
|
MXRA7
|
matrix-remodelling associated 7
|
NPDC1
|
neural proliferation, differentiation and control, 1
|
NPTX2
|
neuronal pentraxin II
|
NREP
|
neuronal regeneration related protein
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
PLS3
|
plastin 3
|
PLVAP
|
plasmalemma vesicle associated protein
|
PRAME
|
preferentially expressed antigen in melanoma
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
PSPH
|
phosphoserine phosphatase
|
PTCH1
|
patched 1
|
R3HDM4
|
R3H domain containing 4
|
RABGAP1L
|
RAB GTPase activating protein 1-like
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
RGL1
|
ral guanine nucleotide dissociation stimulator-like 1
|
RGS1
|
regulator of G-protein signaling 1
|
RGS5
|
regulator of G-protein signaling 5
|
RIOK3
|
RIO kinase 3
|
RNASET2
|
ribonuclease T2
|
S100A2
|
S100 calcium binding protein A2
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
SCPEP1
|
serine carboxypeptidase 1
|
SDC2
|
syndecan 2
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
SSR4
|
signal sequence receptor, delta
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
TBC1D9B
|
TBC1 domain family, member 9B (with GRAM domain)
|
TGFA
|
transforming growth factor, alpha
|
TMEM204
|
transmembrane protein 204
|
TMEM45A
|
transmembrane protein 45A
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
TPD52
|
tumor protein D52
|
TRIB2
|
tribbles pseudokinase 2
|
TXNIP
|
thioredoxin interacting protein
|
VIM
|
vimentin
|